Table 3.
Relative organ weight of rats after treatment of the extract.
| Group | Liver weigth Index (%) |
Kidney weigth Index (%) |
||
|---|---|---|---|---|
| Female | Male | Female | Male | |
| A | 3.21 ± 0.32 | 3.20 ± 0.12 | 0.63 ± 0.02 | 0.58 ± 0.01 |
| B | 3.13 ± 0.28 | 3.26 ± 0.19 | 0.68 ± 0.11 | 0.62 ± 0.05 |
| C | 3.31 ± 0.13 | 3.13 ± 0.06 | 0.65 ± 0.09 | 0.64 ± 0.02 |
| D | 3.15 ± 0.16 | 3.12 ± 0.25 | 0.61 ± 0.06 | 0.68 ± 0.17 |
| E | 3.13 ± 0.08 | 3.14 ± 0.15 | 0.61 ± 0.03 | 0.68 ± 0.09 |
| F | 3.10 ± 0.05 | 3.17 ± 0.30 | 0.63 ± 0.05 | 0.66 ± 0.11 |
A: control group, administered by 2% PGA suspension for 90 days.
B: treatment group, administered by the extract of C. fistula 300 mg/kg of body weight once a day for 90 days.
C: treatment group, administered by the extract of C. fistula 600 mg/kg of body weight once a day for 90 days.
D: treatment group, administered by the extract of C. fistula 1000 mg/kg of body weight once a day for 90 days.
E: satelite experiment group, administered by the extract of C. fistula 1000 mg/kg of body weight once a day for 90 days and kept for another 30 days without any treatment.
F : satelite control group, administered by 2% PGA suspension for 90 days, and kept for another 30 days without any treatment.